Search

Results to be presented at the upcoming American Society of Clinical Oncology (ASCO) meeting suggest combination immunotherapy may help more people with the most common form of lung cancer.

… Wednesday, June 1, 2016 Summary Immunotherapy has emerged as a promising new treatment option for people with lung cancer . MSK scientists are conducting research to enable more patients to benefit from immunotherapies, at earlier stages. We spoke with MSK lung cancer and immunotherapy expert Matthew

Memorial Sloan Kettering Cancer Center (MSK) has been ranked as the number two hospital for cancer care in the nation, according to U.S. News & World Report in its annual listing of Best Hospitals. Since the inception of the rankings 30 years ago, MSK has held either the first or second spot each year for cancer care. MSK was also ranked first in gynecology.

… Tuesday, July 30, 2019 Memorial Sloan Kettering Memorial Sloan Kettering Cancer Center (MSK) has been ranked as the number two hospital for cancer care in the nation, according to  U.S. News & World Report  in its annual listing of Best Hospitals. Since the inception of the rankings 30 years ago, MSK

Preliminary results of a randomized, international Phase II trial of VEGF Trap (aflibercept) show activity in patients with recurrent epithelial ovarian cancer (EOC) who had received three or four prior chemotherapy regimens and had become resistant to platinum-based chemotherapy agents.

… Saturday, June 2, 2007 Preliminary results of a randomized, international Phase II trial of VEGF Trap (aflibercept) show activity in patients with recurrent epithelial ovarian cancer (EOC) who had received three or four prior chemotherapy regimens and had become resistant to platinum-based chemotherapy

Medical oncologist Ping Chi has been named an incumbent of a Geoffrey Beene Junior Faculty Chair, a position designed to provide funding to outstanding young researchers at a crucial early stage in their careers.

… Thursday, March 1, 2012 Summary Medical oncologist Ping Chi has been named an incumbent of a Geoffrey Beene Junior Faculty Chair, a position designed to provide funding to outstanding young researchers at a crucial early stage in their careers. Ping Chi has been named an incumbent of a Geoffrey Beene

The Society of Memorial Sloan Kettering Cancer Center (MSK), an organization of dedicated volunteers, raised an extraordinary $6.6 million in their 2022–2023 season, fueling innovations in cancer care, research, and education.

… Monday, June 10, 2024 The Society of Memorial Sloan Kettering Cancer Center (MSK), an organization of dedicated volunteers, raised an extraordinary $6.6 million in their 2022–2023 season, fueling innovations in cancer care, research, and education. Infographic text: The Society raised an extraordinary

In this Q&A, medical oncologist Martee Hensley discusses the diagnosis and treatment of leiomyosarcoma and other uterine sarcomas.

… Thursday, July 14, 2016 Summary Memorial Sloan Kettering has a team of experts who specialize in the diagnosis and treatment of uterine sarcomas . Here, medical oncologist Martee Hensley tells us the latest developments in leiomyosarcoma and how our team approach benefits people with these rare cancers

Women who have reconstructive surgery after mastectomy and radiation for breast cancer are usually more satisfied with the results when their own tissue is used instead of implants.

… Thursday, December 8, 2016 Summary Women undergoing mastectomy for breast cancer have two main options for reconstructive surgery : artificial implants or flap surgery using their own tissue. A new study looked at these options in women who received radiation after mastectomy and found that those whose

A new drug for ovarian cancer, which was developed based on lab research at MSK, is transforming the possibilities for patients like Ellen Coopersmith.

… Thursday, September 11, 2025 VIDEO | 02:38 Watch How a Lab Discovery Sparked New Treatment for Rare Ovarian Cancer Every cancer breakthrough begins years before it offers patients new hope. Our series Saved by Science takes you inside MSK’s world class research labs, where you’ll see patients meet the

The Thoracic Surgery Oncology Group (TSOG) is a joint initiative between the American Association for Thoracic Surgery and the Fiona & Stanley Druckenmiller Center for Lung Cancer Research at Memorial Sloan Kettering Cancer Center (MSK).

… Friday, March 15, 2024 The Thoracic Surgery Oncology Group (TSOG) is a joint initiative between the  American Association for Thoracic Surgery and the  Fiona & Stanley Druckenmiller Center for Lung Cancer Research at Memorial Sloan Kettering Cancer Center (MSK). TSOG is a network of thoracic surgeons

The Peritoneal Surface Malignancies Consortium Group is a national, multidisciplinary collaboration of surgical and medical gastrointestinal oncology specialists from top cancer centers. The group recently published a series of updated consensus guidelines for the clinical management of peritoneal metastases related to a variety of gastrointestinal malignancies. In this Q&A with Dr. Michael Foote we discuss discuss the major updates for the management of colorectal cancer and appendiceal cancer peritoneal metastases and how the changes will improve patient outcomes and streamline patient care.

… Tuesday, December 23, 2025 A Q&A with  Michael Foote, MD , MSK Gastrointestinal Medical Oncologist and member of the Peritoneal Surface Malignancies Consortium Group The Peritoneal Surface Malignancies Consortium Group (PSM Consortium Group) is a national, multidisciplinary collaboration of surgical